『AbbottTalks』のカバーアート

AbbottTalks

AbbottTalks

著者: DeviceTalks Podcast Network
無料で聴く

このコンテンツについて

Over the past few years the world has come to recognize Abbott as a company dedicated to helping people live fuller and healthier lives. In this podcast series we'll talk with the healthcare leaders, the executives, and the engineers who are working everyday to develop new technologies to help people live their best lives.DeviceTalks Podcast Network
エピソード
  • S3 E2 - Can NeuroSphere’s connectivity deliver happier, healthier lives to more neuromodulation patients?
    2025/06/03

    In this episode of AbbottTalks, we dive into the surprising origins of neuromodulation, kicking off with a shocker (literally)—treating headaches with electric fish.

    Neuromodulation expert Yagna Pathak, PhD, Medical Science Manager of Medical Affairs at Abbott’s Neuromodulation business, explains how therapies like spinal cord and deep brain stimulation have evolved, detailing their impact on chronic pain and movement disorders. She outlines how Abbott is expanding neuromodulation applications through research in treatment-resistant depression and by integrating AI, wearables, and digital health tools.

    Pathak also shares how connected care technologies—including the Neurosphere Virtual Clinic and the new Neurosphere Digital Health app—are improving patient outcomes. These platforms enhance access, enable timely interventions, and provide valuable educational resources for patients and providers.

    Thank you to Cirtec Medical for sponsoring this episode of AbbottTalks. For more information on how Cirtec Medical works with medical device companies, visit https://www.cirtecmed.com/, and to learn more about Cirtec Medica’s Simplifi Platform, click: https://www.devicetalks.com/wp-content/uploads/2025/06/simpifi-overview_litsheet.pdf

    Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

    続きを読む 一部表示
    46 分
  • S3 E1 - How Abbott built AVEIR™ DR pacemakers to be smaller, leadless, and able to talk with each other
    2025/04/25

    AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders.

    Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for Abbott's Cardiac Rhythm Management, to explore the engineering evolution of the pacemaker—and where it’s headed next.

    Charan reflects on the remarkable transformation of pacemakers from large, wired implants to compact, leadless systems that dramatically improve patient outcomes. He details Abbott’s development of the AVEIR™ DR dual chamber leadless pacemaker system, the first of its kind to enable synchronized communication between the atrium and ventricle without leads, using Abbott’s proprietary i2i™ (implant-to-implant) technology.

    The conversation dives deep into conduction system pacing, modular upgrades, and how Abbott is shaping the future of cardiac care for millions of patients. The episode closes with a powerful story of a former professional surfer whose life was transformed by Abbott’s innovation—an example of technology enabling patients to reclaim their lives.

    Thank you to FPT Americas for sponsoring this episode of AbbottTalks. For more information on how FPT works with medical device companies, visit https://fptsoftware.com/


    Thank you for listening to the AbbottTalks Podcast. To subscribe to the show on your favorite podcast player, click here: https://abbotttalks.castos.com/subscribe.

    続きを読む 一部表示
    1 時間 4 分
  • S2 E7 - Abbott’s Sundareswaran envisions TEAM-HF & earlier interventions to redefine heart failure outcomes
    2024/12/17

    In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott’s pioneering work in heart failure care, focusing on technologies that improve outcomes and empower earlier interventions. Sundareswaran’s path to MedTech began with a shift from computer engineering to biomedical research, where his early work studying blood flow patterns in children with congenital heart disease sparked a passion for solving cardiovascular challenges. This passion led him to roles at Thoratec, St. Jude Medical, and ultimately Abbott, where he has spent years advancing heart failure care. The conversation highlights Abbott’s CardioMEMS™ Heart Failure System, a device enabling remote pulmonary artery pressure monitoring to reduce hospitalizations, and the HeartMate 3 LVAD, which provides life-extending support for patients with advanced heart failure. Sundareswaran also discusses the new TEAM-HF clinical trial, which combines CardioMEMS and HeartMate 3 to identify patients earlier and deliver timely, effective interventions.

    This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/

    Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe

    続きを読む 一部表示
    57 分

AbbottTalksに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。